Home Impurity Ibrutinib CS-O-59353

Ibrutinib Impurity 107

Impurity API Family: Ibrutinib CAT No. CS-O-59353
Enquire
Product Detail

Ibrutinib Impurity 107

Ibrutinib Impurity
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category Impurity
API Family Ibrutinib
Storage Refer MSDS for complete information.
Hazard Information Refer MSDS for complete information.

Ibrutinib Impurity 107 Product Information

Ibrutinib Impurity 107 is listed under Impurity. It is associated with Ibrutinib and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-59353.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
Ibrutinib Impurity 107
CAS No.
-
CAT No.
CS-O-59353
Molecular Formula
C48H46N10O4
Molecular Weight
826.96
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
C(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=C(C6=C(C7=CC=C(OC8=CC=CC=C8)C=C7)N([C@H]9CN(C(C=C)=O)CCC9)N=C6N)N=C52)CCC1)=O
IUPAC Name
1-((R)-3-(6-(1-((R)-1-acryloylpiperidin-3-yl)-3-amino-5-(4-phenoxyphenyl)-1H-pyrazol-4-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
Hazard Compound
Refer MSDS for complete information.

Description

Overview
Useful research chemical for a range of applications.
Synonyms
1-((R)-3-(6-(1-((R)-1-acryloylpiperidin-3-yl)-3-amino-5-(4-phenoxyphenyl)-1H-pyrazol-4-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
Application Notes
Useful research chemical for a range of applications.
References
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.